Company / Profit Margin
SUTRO BIOPHARMA, INC. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-366.6%
FY2025
5-year range
-366.6% / -130.4%
FY2021-FY2025
Trend
-108.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -170.6% to -366.6% over the past 2 years.
Based on SEC 10-K filings.
-366.6% in FY2025 with a 5-year CAGR of -274.7%.
Declined from -170.6% to -366.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -87.6pp
- 5-Year Change
- -274.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 108.4% year-over-year.
- Peak profit margin was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -366.6% | -108.4% |
| FY2024 | -175.9% | -3.1% |
| FY2023 | -170.6% | +38.9% |
| FY2022 | -279.0% | -113.9% |
| FY2021 | -130.4% | -41.9% |
| FY2020 | -91.9% | -141.6% |
| FY2019 | -38.0% | -1435.1% |
| FY2018 | 2.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026